Tapewire

Nasdaq · USD

TIL

Instil Bio, Inc.

Export transactions ↓
Tapewire entity
7177
SEC CIK
0001789769
Parsed reports
83

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2026 Filed Jun 12, 2026 14:38 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $7.93 $0.00
Disclosure

SEC source: 0001851336-26-000002 · wk-form4_1781289534.xml · derivative · entry 1

Matcham George · CIK 0001851336 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2036-06-10

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
June 11, 2026 Filed Jun 12, 2026 14:40 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $7.93 $0.00
Disclosure

SEC source: 0001402856-26-000003 · wk-form4_1781289604.xml · derivative · entry 1

McGaughy R Kent Jr · CIK 0001402856 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2036-06-10

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
June 11, 2026 Filed Jun 12, 2026 14:38 UTC GrantStock Option (Right to Buy) · Derivative 0 $0.00 Strike: $7.93 $0.00
Disclosure

SEC source: 0001555918-26-000002 · wk-form4_1781289500.xml · derivative · entry 1

Gibson Neil W · CIK 0001555918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2036-06-10

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
June 11, 2026 Filed Jun 12, 2026 18:37 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $7.93 $0.00
Disclosure

SEC source: 0001791742-26-000002 · wk-form4_1781289457.xml · derivative · entry 1

Binder Gwendolyn · CIK 0001791742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2036-06-10

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
September 10, 2025 Filed Sep 12, 2025 21:00 UTC
Laumas SandeepCFO and CBO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 13,000 $0.00 Strike: $12.68 $0.00
Disclosure

SEC source: 0001789769-25-000087 · wk-form4_1757710851.xml · derivative · entry 6

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 13,000 shares

Expires 2033-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 21:00 UTC
Laumas SandeepCFO and CBO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 17,000 $0.00 Strike: $11.60 $0.00
Disclosure

SEC source: 0001789769-25-000087 · wk-form4_1757710851.xml · derivative · entry 5

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 17,000 shares

Expires 2034-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 21:00 UTC
Laumas SandeepCFO and CBO
SaleCommon Stock 12,461 $23.88 $297,568.68
Disclosure

SEC source: 0001789769-25-000087 · wk-form4_1757710851.xml · nonDerivative · entry 4

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
September 10, 2025 Filed Sep 12, 2025 21:00 UTC
Laumas SandeepCFO and CBO
SaleCommon Stock 17,539 $23.04 $404,098.56
Disclosure

SEC source: 0001789769-25-000087 · wk-form4_1757710851.xml · nonDerivative · entry 3

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,461

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Read SEC document
September 10, 2025 Filed Sep 12, 2025 21:00 UTC
Laumas SandeepCFO and CBO
Exercise / conversionCommon Stock 13,000 $12.68 $164,840.00
Disclosure

SEC source: 0001789769-25-000087 · wk-form4_1757710851.xml · nonDerivative · entry 2

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 21:00 UTC
Laumas SandeepCFO and CBO
Exercise / conversionCommon Stock 17,000 $11.60 $197,200.00
Disclosure

SEC source: 0001789769-25-000087 · wk-form4_1757710851.xml · nonDerivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2025 Filed May 29, 2025 19:10 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $26.75 $0.00
Disclosure

SEC source: 0001789769-25-000066 · wk-form4_1748560241.xml · derivative · entry 1

Matcham George · CIK 0001851336 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2035-05-27

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
May 28, 2025 Filed May 29, 2025 19:09 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $26.75 $0.00
Disclosure

SEC source: 0001789769-25-000064 · wk-form4_1748560149.xml · derivative · entry 1

McGaughy R Kent Jr · CIK 0001402856 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2035-05-27

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
May 28, 2025 Filed May 29, 2025 19:12 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $26.75 $0.00
Disclosure

SEC source: 0001789769-25-000068 · wk-form4_1748560318.xml · derivative · entry 1

Gibson Neil W · CIK 0001555918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2035-05-27

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
May 28, 2025 Filed May 29, 2025 23:13 UTC GrantStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $26.75 $0.00
Disclosure

SEC source: 0001789769-25-000070 · wk-form4_1748560384.xml · derivative · entry 1

Binder Gwendolyn · CIK 0001791742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2035-05-27

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
April 25, 2025 Filed Apr 28, 2025 17:00 UTC
Crouch BronsonDirector · CEO and Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 105,157 $0.00 Strike: $12.78 $0.00
Disclosure

SEC source: 0001789769-25-000040 · wk-form4_1745874009.xml · derivative · entry 1

Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,157

Underlying: Common Stock · 105,157 shares

Expires 2035-04-24

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
April 25, 2025 Filed Apr 28, 2025 21:00 UTC
Laumas SandeepCFO and CBO
GrantEmployee Stock Option (right to buy) · Derivative 44,851 $0.00 Strike: $12.78 $0.00
Disclosure

SEC source: 0001789769-25-000041 · wk-form4_1745874035.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,851

Underlying: Common Stock · 44,851 shares

Expires 2035-04-24

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
September 18, 2024 Filed Sep 23, 2024 13:07 UTC
Crouch BronsonDirector · CEO and Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $66.10 $0.00
Disclosure

SEC source: 0001789769-24-000093 · wk-form4_1727111266.xml · derivative · entry 1

Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-09-17

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
September 18, 2024 Filed Sep 23, 2024 17:12 UTC
Laumas SandeepCFO and CBO
GrantEmployee Stock Option (right to buy) · Derivative 45,000 $0.00 Strike: $66.10 $0.00
Disclosure

SEC source: 0001789769-24-000095 · wk-form4_1727111515.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-09-17

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 13, 2024 Filed Jun 13, 2024 17:03 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001789769-24-000067 · wk-form4_1718312594.xml · derivative · entry 1

Matcham George · CIK 0001851336 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
June 13, 2024 Filed Jun 13, 2024 17:02 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001789769-24-000065 · wk-form4_1718312526.xml · derivative · entry 1

McGaughy R Kent Jr · CIK 0001402856 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
June 13, 2024 Filed Jun 13, 2024 17:01 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001789769-24-000064 · wk-form4_1718312468.xml · derivative · entry 1

Gibson Neil W · CIK 0001555918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
June 13, 2024 Filed Jun 13, 2024 21:02 UTC GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001789769-24-000066 · wk-form4_1718312563.xml · derivative · entry 1

Binder Gwendolyn · CIK 0001791742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

Read SEC document
February 10, 2024 Filed Feb 13, 2024 17:36 UTC
Crouch BronsonDirector · CEO and Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 120,000 $0.00 Strike: $11.60 $0.00
Disclosure

SEC source: 0001789769-24-000023 · wk-form4_1707863794.xml · derivative · entry 1

Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
February 10, 2024 Filed Feb 13, 2024 22:40 UTC
Laumas SandeepCFO and CBO
GrantEmployee Stock Option (right to buy) · Derivative 80,000 $0.00 Strike: $11.60 $0.00
Disclosure

SEC source: 0001789769-24-000025 · wk-form4_1707863993.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2034-02-09

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 14, 2023 Filed Jan 10, 2024 19:49 UTC GrantStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001789769-24-000007 · wk-form4_1704934135.xml · derivative · entry 1

Matcham George · CIK 0001851336 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,500 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
June 14, 2023 Filed Jan 10, 2024 19:50 UTC GrantStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001789769-24-000010 · wk-form4_1704934245.xml · derivative · entry 1

McGaughy R Kent Jr · CIK 0001402856 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,500 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
June 14, 2023 Filed Jan 10, 2024 19:49 UTC GrantStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001789769-24-000008 · wk-form4_1704934169.xml · derivative · entry 1

Gibson Neil W · CIK 0001555918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,500 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
June 14, 2023 Filed Jan 10, 2024 19:48 UTC
Nielsen JackDirector
GrantStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001789769-24-000006 · wk-form4_1704934071.xml · derivative · entry 1

Nielsen Jack · CIK 0001602402 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,500 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
June 14, 2023 Filed Jan 11, 2024 01:10 UTC GrantStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001789769-24-000011 · wk-form4_1704935440.xml · derivative · entry 1

Binder Gwendolyn · CIK 0001791742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,500 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
January 18, 2023 Filed Jan 20, 2023 21:06 UTC
Ray SumitaChief Legal and Admin Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001789769-23-000006 · wf-form4_167424877162085.xml · derivative · entry 2

Ray Sumita · CIK 0001579629 · Chief Legal and Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-01-17

F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on January 18, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
January 08, 2023 Filed Jan 20, 2023 16:09 UTC
Crouch BronsonDirector · CEO and Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 1,000,000 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001789769-23-000010 · wf-form4_167424895139494.xml · derivative · entry 1

Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2033-01-07

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
January 08, 2023 Filed Jan 20, 2023 21:06 UTC
Ray SumitaChief Legal and Admin Officer
GrantEmployee Stock Option (right to buy) · Derivative 415,000 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001789769-23-000006 · wf-form4_167424877162085.xml · derivative · entry 1

Ray Sumita · CIK 0001579629 · Chief Legal and Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 415,000

Underlying: Common Stock · 415,000 shares

Expires 2033-01-07

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
January 08, 2023 Filed Jan 20, 2023 21:08 UTC
Laumas SandeepCFO and CBO
GrantEmployee Stock Option (right to buy) · Derivative 415,000 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001789769-23-000008 · wf-form4_167424886036425.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 415,000

Underlying: Common Stock · 415,000 shares

Expires 2033-01-07

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
September 06, 2022 Filed Sep 6, 2022 17:41 UTC
MOORE TIMOTHY L.Chief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 750,000 $0.00 Strike: $5.30 $0.00
Disclosure

SEC source: 0001789769-22-000081 · wf-form4_166250048300587.xml · derivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2032-09-05

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on September 6, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
May 20, 2022 Filed May 25, 2022 18:08 UTC
Chiruvolu VijayChief Technical Officer
GrantEmployee Stock Option (right to buy) · Derivative 154,237 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001789769-22-000055 · wf-form4_165351647029928.xml · derivative · entry 1

Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,237

Underlying: Common Stock · 154,237 shares

Expires 2032-05-19

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on May 20, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
May 20, 2022 Filed May 25, 2022 17:57 UTC GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001789769-22-000045 · wf-form4_165351582144757.xml · derivative · entry 1

Matcham George · CIK 0001851336 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
May 20, 2022 Filed May 25, 2022 17:59 UTC GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001789769-22-000047 · wf-form4_165351593893691.xml · derivative · entry 1

McGaughy R Kent Jr · CIK 0001402856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
May 20, 2022 Filed May 25, 2022 18:04 UTC GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001789769-22-000053 · wf-form4_165351623194991.xml · derivative · entry 1

Gibson Neil W · CIK 0001555918 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
May 20, 2022 Filed May 25, 2022 18:02 UTC
Nielsen JackDirector
GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001789769-22-000051 · wf-form4_165351614718058.xml · derivative · entry 1

Nielsen Jack · CIK 0001602402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
May 20, 2022 Filed May 25, 2022 22:01 UTC GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001789769-22-000049 · wf-form4_165351607627422.xml · derivative · entry 1

Binder Gwendolyn · CIK 0001791742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 16:56 UTC OtherCommon Stock 260,323 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007150 · doc1.xml · nonDerivative · entry 1

McGaughy R Kent Jr · CIK 0001402856 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,218,467

F2 · kind: The LP distributed these shares to its partners on a pro rata basis, for no consideration.

F1 · ownership.nature: The securities are held by Ibisbill, LP (the "LP"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the shares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to share voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial ownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein.

Read SEC document
March 04, 2022 Filed Mar 7, 2022 17:05 UTC
Chiruvolu VijayChief Technical Officer
GrantEmployee Stock Option (right to buy) · Derivative 257,000 $8.62 Strike: $8.62 $2,215,340.00
Disclosure

SEC source: 0001789769-22-000012 · wf-form4_164669070108181.xml · derivative · entry 1

Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,000

Underlying: Common Stock · 257,000 shares

Expires 2032-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
March 04, 2022 Filed Mar 7, 2022 22:10 UTC
Roberts ZacharyChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 245,000 $8.62 Strike: $8.62 $2,111,900.00
Disclosure

SEC source: 0001789769-22-000016 · wf-form4_164669099729627.xml · derivative · entry 1

Roberts Zachary · CIK 0001851044 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,000

Underlying: Common Stock · 245,000 shares

Expires 2032-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
March 04, 2022 Filed Mar 7, 2022 17:08 UTC
Crouch BronsonDirector · CEO and Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 750,000 $8.62 Strike: $8.62 $6,465,000.00
Disclosure

SEC source: 0001789769-22-000014 · wf-form4_164669088804336.xml · derivative · entry 1

Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2032-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
March 04, 2022 Filed Mar 7, 2022 22:06 UTC
Laumas SandeepCFO and CBO
GrantEmployee Stock Option (right to buy) · Derivative 234,000 $8.62 Strike: $8.62 $2,017,080.00
Disclosure

SEC source: 0001789769-22-000013 · wf-form4_164669078591142.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Common Stock · 234,000 shares

Expires 2032-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
March 04, 2022 Filed Jan 20, 2023 16:11 UTC Amendment
Crouch BronsonDirector · CEO and Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 750,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001789769-23-000014 · wf-form4a_167424910228120.xml · derivative · entry 1

Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2032-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
March 04, 2022 Filed Jan 20, 2023 21:10 UTC Amendment
Laumas SandeepCFO and CBO
GrantEmployee Stock Option (right to buy) · Derivative 234,000 $0.00 Strike: $8.62 $0.00
Disclosure

SEC source: 0001789769-23-000012 · wf-form4a_167424903416782.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · CFO and CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Common Stock · 234,000 shares

Expires 2032-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
October 07, 2021 Filed Oct 8, 2021 20:04 UTC
Roberts ZacharyChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 120,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001789769-21-000063 · wf-form4_163372346517423.xml · derivative · entry 1

Roberts Zachary · CIK 0001851044 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,000

Underlying: Common Stock · 120,000 shares

Expires 2030-05-08

F1 · derivative.exercise_date: Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on October 7, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock.

Read SEC document
September 10, 2021 Filed Sep 13, 2021 22:59 UTC
Roberts ZacharyChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 120,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001789769-21-000059 · wf-form4_163157393793773.xml · derivative · entry 1

Roberts Zachary · CIK 0001851044 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2030-05-08

F1 · derivative.exercise_date: Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on September 10, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock.

Read SEC document
May 11, 2021 Filed May 13, 2021 16:57 UTC
Chiruvolu VijayChief Technical Officer
GrantEmployee Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001789769-21-000038 · wf-form4_162093944052252.xml · derivative · entry 2

Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2031-05-10

F2 · derivative.exercise_date: The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.